Q-Pharm Overview

  • Year Founded
  • 2002

Year Founded

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • Buyout/​LBO

  • Financing Rounds
  • 2

Q-Pharm General Information

Description

Operator of the early-phase clinical trial facility based in Herston, Queensland, Australia. The company specializes in the conduct of early-phase clinical trials, bioequivalence and bioavailability studies and vaccine studies.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Private Equity-Backed
Corporate Office
  • Level 6, Block 8
  • Royal Brisbane and Women's Hospital
  • Herston, Queensland 4006
  • Australia
Primary Industry
Laboratory Services (Healthcare)
Acquirer
Corporate Office
  • Level 6, Block 8
  • Royal Brisbane and Women's Hospital
  • Herston, Queensland 4006
  • Australia

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Q-Pharm Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Q-Pharm‘s full profile, request access.

Request a free trial

Q-Pharm Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Q-Pharm‘s full profile, request access.

Request a free trial

Q-Pharm FAQs

  • When was Q-Pharm founded?

    Q-Pharm was founded in 2002.

  • Where is Q-Pharm headquartered?

    Q-Pharm is headquartered in Herston, Australia.

  • What industry is Q-Pharm in?

    Q-Pharm’s primary industry is Laboratory Services (Healthcare).

  • Is Q-Pharm a private or public company?

    Q-Pharm is a Private company.

  • What is Q-Pharm’s current revenue?

    The current revenue for Q-Pharm is .

  • Who are Q-Pharm’s investors?

    QIMR Berghofer Medical Research Institute has invested in Q-Pharm.

  • When was Q-Pharm acquired?

    Q-Pharm was acquired on 31-Jan-2019.

  • Who acquired Q-Pharm?

    Q-Pharm was acquired by Nucleus Network.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »